Acetaminophen pharmacokinetics in infants and children with congenital heart disease

Jay Holladay1, Peter Winch1,2, James Morse3

  • 1Department of Anesthesiology & Pain Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA.

Paediatric Anaesthesia
|October 20, 2022
PubMed

Insights

Acetaminophen pharmacokinetics in children with congenital heart disease were similar regardless of cyanotic or acyanotic status. This study characterized acetaminophen parameters in pediatric patients following cardiac bypass surgery.

Area of Science:

  • Pediatric pharmacology
  • Cardiovascular surgery
  • Pharmacokinetics

Background:

  • Acetaminophen is a standard analgesic for children undergoing major surgery.
  • Limited data exist on acetaminophen pharmacokinetics in pediatric patients with congenital heart disease, particularly cyanotic types.

Purpose of the Study:

  • To prospectively investigate differences in acetaminophen pharmacokinetics after cardiopulmonary bypass in children with cyanotic versus acyanotic congenital heart disease.

Main Methods:

  • A prospective study included children aged 2-6 years undergoing median sternotomy for Fontan palliation (cyanotic) or two ventricle repair (acyanotic).
  • A single intravenous dose of acetaminophen (15 mg/kg) was administered post-cardiopulmonary bypass.
  • Non-linear mixed effects models were used to describe acetaminophen concentrations, with a two-compartment model with first-order elimination selected.

Main Results:

  • Data from 30 children (15 cyanotic, 15 acyanotic) yielded 208 acetaminophen concentrations.
  • A two-compartment model best described the data.
  • Population pharmacokinetic parameters, including clearance and volume of distribution, were similar between cyanotic and acyanotic groups and comparable to existing literature.

Conclusions:

  • Acetaminophen pharmacokinetics in children following cardiac bypass surgery can be described by a two-compartment model.
  • No significant differences in acetaminophen clearance or volume parameters were observed between children with cyanotic and acyanotic congenital heart disease.
Abstract

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.1K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
279
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
111
Nonlinear Pharmacokinetics: Overview01:19

Nonlinear Pharmacokinetics: Overview

Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
514
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
115
Nonlinear Pharmacokinetics: Role of Transporters01:27

Nonlinear Pharmacokinetics: Role of Transporters

A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
87